McGuire, J. J., Frieling, J. S., Lo, C. H., Li, T., Muhammad, A., Lawrence, H. R., . . . Lynch, C. C. (2021). Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)McGuire, Jeremy J., Jeremy S. Frieling, Chen Hao Lo, Tao Li, Ayaz Muhammad, Harshani R. Lawrence, Nicholas J. Lawrence, Leah M. Cook, y Conor C. Lynch. Mesenchymal Stem Cell-derived Interleukin-28 Drives the Selection of Apoptosis Resistant Bone Metastatic Prostate Cancer. Nature Portfolio, 2021.
Cita MLA (8a ed.)McGuire, Jeremy J., et al. Mesenchymal Stem Cell-derived Interleukin-28 Drives the Selection of Apoptosis Resistant Bone Metastatic Prostate Cancer. Nature Portfolio, 2021.